login
  Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 



a b c d e f g h i j k l m n
o p q r s t u v w x y z


1 - 10 of 51   Items
Two millimetre “ice ball” margin beyond renal tumours adequate for effective cryoablation

Two millimetre “ice ball” margin beyond renal tumours adequate for effective cryoablation

Thursday, 12 Jun 2014
The results from a small, animal study challenge previously unsubstantiated published reports claiming that a five to 10mm “ice ball” margin beyond the tumour is necessary for effective cryoablation. Two millimetre “ice ball” margin beyond renal tumours adequate for effective cryoablation
MicroThermX microwave ablation system at CIRSE

MicroThermX microwave ablation system at CIRSE

Tuesday, 20 Sep 2011
The MicroThermX microwave ablation system (BSD Medical) was featured at BSD’s exhibition booth at the international meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), which was held in Munich, Germany, (10-14 September 2011). MicroThermX microwave ablation system at CIRSE
Positive phase II trial results from the neuroendocrine tumor cohort (mNET) of Delcath’s chemosaturation system

Positive phase II trial results from the neuroendocrine tumor cohort (mNET) of Delcath’s chemosaturation system

Monday, 19 Sep 2011
Overall hepatic response rate with chemosaturation treatment among patients was 70%. On the other hand, 30.4 months was the median overall survival in all patients. Positive phase II trial results from the neuroendocrine tumor cohort (mNET) of Delcath’s chemosaturation system

Hepatic chemosaturation—an emerging therapy in interventional oncology

Tuesday, 22 Feb 2011
Hepatic chemosaturation is a minimally invasive technique which delivers high doses of chemotherapy into the liver to more effectively battle tumours, while limiting toxicity to the rest of the body, making it safer than intrahepatic artery perfusion. Hepatic chemosaturation—an emerging therapy in interventional oncology

Radioembolisation prolongs life for inoperable HCC patients

Monday, 12 Jul 2010
More than three-fourths of hepatocellular carcinoma patients are not surgical candidates and radioembolisation with intra-arterial yttrium-90 extends patient survival. Radioembolisation prolongs life for inoperable HCC patients

Direct injection of gold nanoparticles into tumours could be a new treatment for pancreatic cancer

Monday, 12 Jul 2010
A radical new approach to the treatment of the disease, Reed A Omary claims. Direct injection of gold nanoparticles into tumours could be a new treatment for pancreatic cancer
North American Scientific signs definitive agreement

North American Scientific signs definitive agreement

Tuesday, 25 Sep 2007
Nomos Radiation Oncology business sold: September 2007 North American Scientific signs definitive agreement
CMS selected to provide treatment for New Proton Therapy Center

CMS selected to provide treatment for New Proton Therapy Center

Tuesday, 25 Sep 2007
CMS has been selected by ProCure Treatment Centers: September 2007 CMS selected to provide treatment for New Proton Therapy Center
Visualase announces successful treatment of brain metastases

Visualase announces successful treatment of brain metastases

Tuesday, 25 Sep 2007
completed treatment of the first six patients: September 2007 Visualase announces successful treatment of brain metastases
CMS collaborates with Still River Systems

CMS collaborates with Still River Systems

Tuesday, 25 Sep 2007
CMS to provide treatment planning support: September 2007 CMS collaborates with Still River Systems
Found: 51   Displaying: 1-10
Results: 1 2 3 4 5 Next Go to:

Related Section


Oncology Useful Links

Most popular


Live from VEITH 2014: SUPERB results show 94% freedom from reintervention with nominal deployment of Supera at three years
Wednesday, 19 Nov 2014
Three-year follow-up results of patients treated with the Supera stent show that nominal deployment or slight compression of the device delivers the best outcomes in terms of durability, and that ... Live from VEITH 2014: SUPERB results show 94% freedom from reintervention with nominal deployment of Supera at three years

New deep vein thrombosis guidelines: What you need to know
Thursday, 23 Oct 2014
Suresh Vedantham spoke to Interventional News on the latest from the paper “Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus ... New deep vein thrombosis guidelines: What you need to know

Bioresorbable scaffolds can produce comparable acute results to metal stents
Tuesday, 04 Nov 2014
Speaking at the Asian Society for Vascular Surgery meeting (5–7 September, Hong Kong, China), Andrew Holden commented that studies indicate that bioresorbable scaffolds can produce comparable acute ... Bioresorbable scaffolds can produce comparable acute results to metal stents

Features


Stentoplasty: An “exciting frontier” in spinal augmentation
Thursday, 27 Nov 2014
Stentoplasty, or vertebral body stenting, represents the next step in the evolution of cement spinal augmentation where a stent is placed within the vertebral body followed by infusion of cement. Stentoplasty: An “exciting frontier” in spinal augmentation

CO2 angiography should be more widely used
Thursday, 27 Nov 2014
CO2 angiography can decrease both morbidity and mortality for patients, in certain clinical scenarios. For those driven by economics, the cost of 100cc of CO2 is approximately three cents. Its use is ... CO2 angiography should be more widely used

Profiles


Gao-Jun Teng
Thursday, 11 Dec 2014
In the future, will interventional radiology be a subspecialty of radiology, or surgery? asks Gao-J... Gao-Jun Teng

José Ignacio Bilbao Jaureguízar
Wednesday, 08 Oct 2014
“No matter what their future orientation, interventional radiologists involved in interventional ... José Ignacio Bilbao Jaureguízar

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions